Searched for
HETEROLOGOUS BOOSTER DOSE
Covid jab Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per doseThe move comes after a letter was written by Prakash Kumar Singh, Director, Serum Institute of India (SII) to the Union health ministry on ...- Bharat Biotech's nasal Covid vaccine iNCOVACC launchedThe announcement regarding the launch of iNCOVACC on January 26 was made last week by the company’s chairman and managing director. The nas...
- Booster dose of Covishield offers best immune response: Lancet studyFor both binding and functional antibodies, in participants primed with Covishield, homologous boosting with Covishield offers better immun...
- On January 26, India's first COVID intranasal vaccination iNCOVACC will go on saleiNCOVACC, a brand-new domestic drug, has been introduced by Bharat Biotech to aid in the fight against COVID 19. The nasal Covid vaccine ha...
- SII seeks inclusion of Covid jab Covovax in CoWIN portal as heterologous booster dose for adultsThe Drug Controller General of India (DCGI) on January 16 approved market authorisation for Covovax as a heterologous booster dose for adul...
- Covovax gets nod as booster doseThe drug regulator has approved Covovax as a heterologous booster dose for adults administered with two doses of Covishield or Covaxin, sou...
- DGCI approves Covid-19 vaccine Covovax as heterologous booster dose"The Subject Expert Committee of the CDSCO on Wednesday deliberated on the issue and had recommended for market authorisation of Covid jab ...
- Govt may not procure Bharat Biotech's intranasal Covid vaccine iNNOVACCBharat Biotech has made its intranasal Covid-19 vaccine iNNOVACC available on CoWin, priced at ₹800 per dose for private markets and ₹325 f...
- Govt panel recommends market authorisation for Covovax jab as heterologous booster dosePrakash Kumar Singh, director (government and regulatory affairs) at Serum Institute of India (SII) had recently written a letter to Drugs ...
- Govt panel likely to decide on Covovax as a heterologous booster dose for adults on WednesdayPrakash Kumar Singh, Director of Government and Regulatory Affairs at the Serum Institute of India (SII), had written a letter to the the D...
- Bharat Biotech's intranasal vaccine Incovacc to debut on Co-WinThis is the world's first intranasal vaccine for Covid-19 to receive approval for the primary 2-dose schedule, and as a heterologous booste...
- Bharat Biotech’s intranasal vaccine ‘iNCOVACC’ receives CDSCO approval under restricted useThe Central Drugs Standard Control Organisation (CDSCO) gave its nod to the vaccine for use as both primary series as well as a heterologou...
- SEC to review Bharat Bio's intranasal jab for use as booster soonCovaxin - and has submitted the data to the Drugs Controller General of India (DCGI) for the review. Hyderabad based Bharat Biotech has sou...
- Bharat Biotech seeks nod for intranasal Covid vaccineAccording to the vaccine maker, it conducted two separate and simultaneous clinical trials to evaluate its intranasal vaccine (BBV154) as a...
- Vaccinated with Covaxin or Covishield? You may take Corbevax as precaution doseThe government has approved Biological E's Corbevax as a precaution dose for those above 18 years fully vaccinated with either Covishield o...
- NTAGI has found Corbevax efficient as a booster, govt may soon recommend it: Drug Controller General of IndiaThe National Technical Advisory Group on Immunisation (NTAGI) which reviewed the data of Corbevax earlier had found significant antibody re...
- Corbevax gets DCGI nod as heterologous Covid booster dose for adultsThe vaccine can be administered after 6 months of administration of primary vaccination (two doses) of Covaxin or Covishield vaccines for r...
- Covid: Govt unlikely to allow different vaccine as boosterA study showed that if the booster is the same as the first two doses, it boosts immunity well, but when the booster dose is different, the...
- PGI Chandigarh gets nod to study vaccine mixingThe study aims to discover how a person fully vaccinated with either Covishield or Covaxin responds to a booster of the other vaccine (hete...
- NIE plans study on booster for those with comorbiditiesThe Indian Council of Medical Research's NIE has proposed to conduct phase-2 safety and immunogenicity study specifically on people with co...
Load More
